Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma

Cancer Letters

Volumn 248, Issue 2, 2007, Pages 192-197

  Mulaomerović, Adaleta ^a   Halilbašić, Alma ^b   Čičkušić, Elmir ^b   Zavašnik Bergant, Tina ^c   Begić, Lejla ^a   Kos, Janko ^d  

^a UNIVERSITY OF TUZLA   (Bosnia and Herzegovina)

^b University Clinical Center   (Bosnia and Herzegovina)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cystatin C; Dendritic cells; Non Hodgkin lymphoma; Relapse

Indexed keywords

BIOLOGICAL MARKER; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYSTATIN C; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD DONOR; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CREATININE; CYSTATINS; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HISTORY, 17TH CENTURY; HUMANS; IMMUNOTHERAPY; LYMPH NODES; LYMPHOMA, B-CELL; MALE; MICROSCOPY, CONFOCAL; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33847333281     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.07.004     Document Type: Article

References (26)

1. Henskens Y.M.C., Veerman E.C.I., and Amerongen A.V.N. Cystatins in health and diseases. Biol. Chem. Hoppe-Seyler 377 (1996) 71-86
2. Pierre P., and Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93 (1998) 1135-1145
3. Abrahamson M., Olafsson I., Palsdottir A., Ulvsback J., Lundwall A., Jensson O., and Grubb A. Structure and expression of the human cystatin C gene. Biochem. J. 268 (1990) 287-294
4. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin. Nephrol. 38 (1992) 20-27
5. Jacobsson B., Lignelid H., and Bergerheim U.S.R. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful markers for renal cell carcinomas. Histopathology 26 (1995) 559-564
6. Finney H., Newman D.J., Gruber W., Merle P., and Price C.P. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems. Clin. Chem. 43 (1997) 1016-1022
7. Kos J., Krašovec M., Cimerman N., Nielsen H.J., Christensen I.J., and Brünner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin. Cancer Res. 6 (2000) 505-511
8. Huh C.G., Häkansson K., Nathanson C.M., Thorgeirsson U.P., Grubb A., Abrahamson M., and Karlsson S. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. J. Clin. Pathol. Mol. Pathol. 52 (1999) 332-340
9. Kos J., Štabuc B., Schweiger A., Krašovec M., Cimerman N., Kopitar Jerala N., et al. Cathepsins B, H, L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin. Cancer Res. 3 (1997) 1815-1822
10. Strojnik T., Kos J., Židanek B., Golouh R., and Lah T. Cathepsin B immunohistochemical staining in tumour and endothelial cells is a new prognostic factor for survival in patients with brain tumours. Clin. Cancer Res. 5 (1999) 559-567
11. Zavašnik-Bergant V., Repnik U., Schweiger A., Romih R., Jeras M., Turk V., and Kos J. Differentiation and maturation dependent content, localization and secretion of cystatin C in human dendritic cells. J. Leukoc. Biol. 78 (2005) 122-134
12. Cimerman N., Trstenjak Prebanda M., Turk B., Popovič T., Dolenc I., and Turk V. Interaction of cystatin C variants with papain and human cathepsins B, H, and L. J. Enz. Inhib. 14 (1999) 167-174
13. Zavašnik-Bergant V., Schweiger A., Bevec T., Golouh R., Turk V., and Kos J. Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes. Immunology 112 (2004) 378-385
14. Turk V., Kos J., and Turk B. Cysteine cathepsins (proteases) - On the main stage of cancer?. Cancer Cell 5 (2004) 409-410
15. J. Kos, T. Lah, Cystatins in human biology, in: N. Kopitar Jerala, E. Žerovnik (Eds.), Molecular Anatomy and Physiology of Proteins, NOVA Science Publishers, Inc., New York, in press. ISBN-60021-233-6.
16. Keppler D. Towards novel anti-cancer strategies based on cystatin function. Cancer Lett. 235 (2005) 159-176
17. Strojan P., Svetic B., Šmid L., and Kos J. Serum cystatin C in patients with head and neck carcinoma. Clin. Chim. Acta 344 (2004) 155-161
18. Kos J., Krašovec M., Cimerman N., Nielsen H.J., Christensen I.J., and Brunner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera of patients with colorectal cancer: relation to prognosis. Clin. Cancer Res. 6 (2000) 505-511
19. Poteriaeva O.N., Usova T.A., Levina O.A., Iarygina E.S., and Korolenko T.A. Immunoenzyme technique for analysis of cystatin C in serum of patients with hemoblastosis. Klin. Lab. Diagn. 7 (2003) 35-38
20. Newman D.J., Thakker H., Edwards R.G., Wilkie M., White T., and Grubb A.O. Serum cystatin C by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 47 (1995) 312-318
21. Laterza O.F., Price C.P., and Scott M.G. Cystatin C: an improved estimator of glomerular filtration rate. Clin. Chem. 48 (2002) 699-707
22. Cimerman N., Brguljan P.M., Krašovec M., Šušković S., and Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin. Chim. Acta 300 (2000) 83-95
23. Finney H., Williams A.H., and Price C.P. Serum cystatin C in patients with myeloma. Clin. Chim. Acta 309 (2001) 1-6
24. Bjornadóttir M., Grubb A., and Ólafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand. J. Clin. Lab. Invest. 55 (1995) 617-623
25. Bender A., Sapp A., Schuler G., Steinman R.M., and Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196 (1996) 121-135
26. Steinman R.M., Pack M., and Inaba K. Dendritic cells in T-cell areas of lymphoid organs. Immunol. Rev. 156 (1997) 25-37